DB
AYLA

Dmitry Balyasny’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Dmitry Balyasny’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,761
Closed -$24K – 3405
2022
Q3 		$24K Buy
+23,761
New +$32K ﹤0.01% 2565

Other funds holding AYLA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dmitry Balyasny's AYLA Position: Q4 2022 in Review

Dmitry Balyasny sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q4 2022, closing a stake of 23,761 shares — an estimated $24K sold.

Dmitry Balyasny first reported a position in AYLA in Q3 2022 and held it in 1 quarter. The position peaked at $24K in Q3 2022. 11 funds tracked by Wall St. Rank hold AYLA as of Q4 2022.

  • Dmitry Balyasny reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Dmitry Balyasny sold 23,761 Ayala Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $24K.
  • Dmitry Balyasny first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Dmitry Balyasny's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $24K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.